Table 5 Summary findings of univariate and multivariate significant effects
Univariate | PTCA from Medication | CABG from PTCA | CABG from Medication |
|---|---|---|---|
Increasing age | â–¼ | ||
Gender | â–¼ | ||
Higher educational attainment | â–² | â–¼ | |
mployment | |||
Previous coronary intervention | â–² | â–¼ | |
Hypercholesterolemia | â–¼ | ||
Hypertension | â–¼ | â–¼ | |
Previous MI | |||
Diabetes | |||
Smoking history | |||
Family history: IHD | â–¼ | â–² | |
Family history: Neurological | â–¼ | ||
Family history: MI | |||
Family history: Stroke | |||
Previous cerebral events | â–¼ | â–¼ | |
Arthritis/Rheumatism | |||
Respiratory | |||
Renal complications | |||
GI tract problems | |||
Peripheral vascular disease | |||
Thyroid problems | |||
Varicose veins | |||
LAD artery disease | â–² | â–² | â–² |
Circumflex artery disease | â–² | â–² | |
RCA disease | â–² | â–² | |
Number of vessels diseased | â–² | â–² | |
Ventricular disease | â–² | â–² | |
Angina frequency | â–² | â–² | |
Dyspnoea frequency | |||
Non-cardiac symptoms | |||
Angina functional limitations | â–² | â–² | |
Dyspnoea functional limitations | â–² | â–² | |
SIP: Social behaviour | â–² | â–² | |
SIP: Mobility range | â–² | â–² | |
SIP: Emotional stability | |||
SIP: Somatic autonomy | |||
SIP: Mobility control | |||
Multivariate | PTCA from Medication – 5 | CABG from PTCA – 4 | CABG from Medication – 4 |
Increasing age | â–¼3 | ||
Higher educational attainment | â–¼4 | ||
Previous coronary intervention | â–²2 | â–¼3 | |
Hypertension | â–¼4 | ||
Previous cerebral events | â–¼2 | ||
LAD artery disease | â–²1 | â–²1 | |
Circumflex artery disease | â–²2 | â–²4 | |
Angina frequency | â–²5 | ||
SIP: Mobility range | â–²1 | â–²3 |